CryoCell International Valuation
| CCEL Stock | USD 8.67 0.42 4.62% |
At this time, the firm appears to be overvalued. CryoCell International shows a prevailing Real Value of $8.02 per share. The current price of the firm is $8.67. Our model approximates the value of CryoCell International from analyzing the firm fundamentals such as Profit Margin of (0.28) %, return on equity of 1.29, and Current Valuation of 79.5 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CryoCell International's valuation include:
Price Book 9.7236 | Enterprise Value 79.5 M | Enterprise Value Ebitda (6.69) | Price Sales 2.3018 | Enterprise Value Revenue 2.4971 |
Overvalued
Today
Please note that CryoCell International's price fluctuation is slightly risky at this time. Calculation of the real value of CryoCell International is based on 3 months time horizon. Increasing CryoCell International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CryoCell stock is determined by what a typical buyer is willing to pay for full or partial control of CryoCell International. Since CryoCell International is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CryoCell Stock. However, CryoCell International's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.67 | Real 8.02 | Target 10.0 | Hype 8.67 | Naive 8.08 |
The intrinsic value of CryoCell International's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CryoCell International's stock price.
Estimating the potential upside or downside of CryoCell International helps investors to forecast how CryoCell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CryoCell International more accurately as focusing exclusively on CryoCell International's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CryoCell International's intrinsic value based on its ongoing forecasts of CryoCell International's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CryoCell International's closest peers.
CryoCell International Cash |
|
CryoCell Valuation Trend
Knowing CryoCell International's actual value is paramount for traders when making sound investment determinations. Using both CryoCell International's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
CryoCell Revenue by Product
CryoCell International Total Value Analysis
CryoCell International is currently forecasted to have valuation of 79.5 M with market capitalization of 73.28 M, debt of 10.9 M, and cash on hands of 2.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CryoCell International fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
79.5 M | 73.28 M | 10.9 M | 2.96 M |
CryoCell International Investor Information
About 48.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.07. CryoCell International last dividend was issued on the 15th of November 2024. CryoCell International may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 10.8 M | 10.3 M |
|
|
CryoCell International Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of CryoCell suggests not a very effective usage of assets in December.CryoCell International Ownership Allocation
The market capitalization of CryoCell International is $73.28 Million. CryoCell International retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.CryoCell International Profitability Analysis
The company reported the previous year's revenue of 31.34 M. Net Loss for the year was (9.52 M) with profit before overhead, payroll, taxes, and interest of 21.54 M.CryoCell International Past Distributions to stockholders
About CryoCell International Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CryoCell International. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CryoCell International based exclusively on its fundamental and basic technical indicators. By analyzing CryoCell International's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CryoCell International's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CryoCell International. We calculate exposure to CryoCell International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CryoCell International's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 26.3 M | 27.7 M | |
| Pretax Profit Margin | (0.38) | (0.36) | |
| Operating Profit Margin | (0.35) | (0.37) | |
| Net Loss | (0.27) | (0.29) | |
| Gross Profit Margin | 0.66 | 0.56 |
A single share of CryoCell International represents a small ownership stake in the entity. As a stockholder of CryoCell, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
CryoCell International Dividends Analysis For Valuation
Please note that CryoCell International has scaled down on payment of dividends at this time. Price Earnings To Growth Ratio is expected to rise to 0.01 this year, although the value of Retained Earnings will most likely fall to (29.4 M).
There are various types of dividends CryoCell International can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of CryoCell shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from CryoCell International directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When CryoCell pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of CryoCell International by the value of the dividends paid out.
CryoCell International Growth Indicators
Investing in growth stocks can be very risky. If the company such as CryoCell International does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 8.3 M | |
| Quarterly Earnings Growth Y O Y | 0.625 |
CryoCell International Current Valuation Indicators
CryoCell International's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final CryoCell International's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CryoCell International, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CryoCell International's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CryoCell International's worth.When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.625 | Earnings Share (1.07) | Revenue Per Share 3.89 | Quarterly Revenue Growth 0.025 | Return On Assets (0) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.